Jing Marantz
Net worth: 6 M $ as of 31/05/2026
Net worth: 6 M $ as of 31/05/2026
Dr. Jing L. Marantz is a Senior Vice President-Medical Affairs at Acceleron Pharma, Inc. She is on the Board of Directors at Krystal Biotech, Inc. Dr. Marantz was previously employed as a Head-Medical Affairs & Senior Vice President by Alnylam Pharmaceuticals, Inc., a Vice President-Medical Affairs by ARIAD Pharmaceuticals, Inc., and a Vice President-Global Medical Affairs by Alexion Pharmaceuticals, Inc. She received her MBA from Haas School of Business, a doctorate degree from Tongji Medical College of Huazhong University of Sci & Tech and a doctorate degree from Medical University of South Carolina.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/02/2026 | 126,012 ( 0.11% ) | 6 M $ | 31/05/2026 | |
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director/Board Member | 07/12/2021 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 09/11/2022 |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Director/Board Member | - |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Director/Board Member | 18/01/2022 |
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 01/11/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2020 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2018 |
| ARIAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Medical University of South Carolina
Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions